Enhanced stability of siRNA-loaded lipid nanoparticles during lyophilization via acetyl-arginine and disaccharides
Summary
RNA-loaded lipid nanoparticles (LNPs) are highly sensitive to temperature fluctuations, which present significant challenges for storage and transportation. Lyophilization is a potential strategy to enhance storage stability; however, the freeze-drying process can subject nanoparticles to stresses that may alter their physicochemical properties and compromise RNA integrity. This study evaluated the effects of formulation composition on the stability and functionality of small interfering RNA (siRNA)-loaded LNPs after lyophilization.
RNA-loaded lipid nanoparticles (LNPs) are highly sensitive to temperature fluctuations, which present significant challenges for storage and transportation. Lyophilization is a potential strategy to enhance storage stability; however, the freeze-drying process can subject nanoparticles to stresses that may alter their physicochemical properties and compromise RNA integrity. This study evaluated the effects of formulation composition on the stability and functionality of small interfering RNA (siRNA)-loaded LNPs after lyophilization. Among the formulations tested, a combination of 10% ( w / v ) trehalose and 50 mM N-acetyl-L-arginine (NALA) most effectively preserved particle size and encapsulation efficiency following freeze-drying. The NALA-based formulation also exhibited improved storage stability across 4 °C, 25 °C, and 40 °C compared to the corresponding arginine-containing formulation. Cryo-TEM analysis revealed that NALA-containing LNPs retained a spherical morphology with a homogeneous internal core after lyophilization, indicating improved structural preservation during freeze-drying. Additionally, reconstituted siRNA-LNPs containing NALA maintained cellular function comparable to pre-lyophilization samples. These findings demonstrate that a stabilizer system based on trehalose and NALA can enhance the stability of lyophilized siRNA-LNPs while preserving their physicochemical properties and biological activity.
Abstract from PubMed Central (PMID 42990940, PMC13734858). This entry was added automatically by our daily literature monitor because it matches the topics we follow; read the full paper at the original source.
Related articles
Preclinical Evaluation of cRGD-Functionalized Lipid-Polymer Hybrid Nanocarriers for Anti-VEGF Gene Therapy in Triple-Negative Breast Cancer
Biomaterials scienceRational optimization of lipid nanoparticles enables efficient and low-activation mRNA delivery to platelets
International journal of nanomedicineAn Update on Blood-Brain Barrier Penetrating Nanoparticles for the Treatment of Glioblastoma
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
